ClinicalTrials.gov
public full text
Public Domain
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE
This is an investigator-initiated trial aimed at assessing the safety and efficacy of anti-BCMA/CD70 CAR-T cells in the treatment of refractory systemic lupus erythematosus.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell Carcinoma#1124348
- Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases#1029879
- Clinical Study of Targeting CD7 CAR-T Cells in the Treatment of Autoimmune Diseases#1010625
- Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease#851290
- CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH#343840
Record · ID 851952
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive